[Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma].
about
[Dopaminergic and somatostatinergic pathways decrease serum thyrotropin in rats bearing the 256-Walker mammary carcinoma].
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@en
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@nl
type
label
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@en
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@nl
prefLabel
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@en
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@nl
P2093
P2860
P1476
[Dopaminergic and somatostatin ...... 256-Walker mammary carcinoma].
@en
P2093
Antonio C Bianco
Edna T Kimura
Osmar Monte
Szulin Zyngier
P2860
P304
P356
10.1590/S0004-27302005000200012
P407
P577
2005-04-01T00:00:00Z